Current efforts in standards development. United States

Med Care. 1996 Dec;34(12 Suppl):DS200-3; discussion DS204-7.

Author

E J Power¹

Affiliation

¹ Health Program, Office of Technology Assessment, Washington, DC, USA.

PMID: 8969327

No abstract available

MeSH terms

Cost-Benefit Analysis*
Economics, Pharmaceutical / standards*
Economics, Pharmaceutical / trends
Humans
United States